LDLR and familial pancreatic carcinoma: We also show that this conjugate specifically targets PDAC in vivo, through LDLR, without causing hepatic and renal damages, and enables the discrimination of advanced PDAC from CP and the detection of liver-disseminated pancreatic cancer cells.